D. Killander
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Cancer Genomics and Diagnostics 24
- Breast Cancer Treatment Studies 14
-
- DNA Repair Mechanisms 7
- Co-authors
- A. Zetterberg (6 shared papers)Mårten Fernö (26 shared papers)Helgi Sigurðsson (13 shared papers)Åke Borg (13 shared papers)Bo Baldetorp (28 shared papers)Håkan Olsson (11 shared papers)Rudolf Rigler (6 shared papers)Sven‐Börje Ewers (7 shared papers)
- Journals
- Experimental Cell Research (22 papers)Acta Oncologica (8 papers)Cytometry (6 papers)Breast Cancer Research and Treatment (5 papers)International Journal of Cancer (5 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
D. Killander
110 papers receiving 4.9k citations
D. Killander's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 1.4k
- Oncology 1.7k
- Otorhinolaryngology 242
- Pathology and Forensic Medicine 727
- Molecular Biology 1.7k
Countries citing papers authored by D. Killander
This map shows the geographic impact of D. Killander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Killander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Killander more than expected).
Fields of papers citing papers by D. Killander
This network shows the impact of papers produced by D. Killander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Killander. The network helps show where D. Killander may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Killander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HER-2/neu amplification predicts poor survival in node-positive breast cancer. | 1990 | 392 |
| 2 | Histologic Classification and Grading of Malignancy in Carcinoma of the Larynx Hit paper breakdown → | 1973 | 378 |
| 3 | 1994 | 345 | |
| 4 | 1990 | 287 | |
| 5 | 1965 | 203 | |
| 6 | 1965 | 203 | |
| 7 | 1994 | 203 | |
| 8 | 1984 | 189 | |
| 9 | ERBB2 amplification in breast cancer with a high rate of proliferation. | 1991 | 164 |
| 10 | 1993 | 163 | |
| 11 | 1965 | 121 | |
| 12 | 1991 | 113 | |
| 13 | 1969 | 104 | |
| 14 | 1976 | 100 | |
| 15 | 1979 | 97 | |
| 16 | 1965 | 90 | |
| 17 | 1990 | 86 | |
| 18 | 1969 | 68 | |
| 19 | 1963 | 67 | |
| 20 | 1965 | 65 |
About D. Killander
D. Killander is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 115 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (24 papers), Breast Cancer Treatment Studies (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers), DNA Repair Mechanisms (7 papers), Breast Lesions and Carcinomas (7 papers), T-cell and B-cell Immunology (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.7k citations), Otorhinolaryngology (242 citations), Pathology and Forensic Medicine (727 citations) and Molecular Biology (1.7k citations). D. Killander has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include A. Zetterberg, Mårten Fernö, Helgi Sigurðsson, Åke Borg, Bo Baldetorp, Håkan Olsson, Rudolf Rigler, Sven‐Börje Ewers, Gary M. Clark and P. Jakobsson. Their work appears in journals such as Experimental Cell Research, Acta Oncologica, Cytometry, Breast Cancer Research and Treatment and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.